Treace Medical Concepts, Inc. (TMCI) Reports In-Line Q1 EPS

Treace Medical Concepts, Inc. (NASDAQ: TMCI) reported Q1 EPS of ($0.25), in-line with the analyst estimate of ($0.25). Revenue for the quarter came in at $52.6 million versus the consensus estimate of $52.7 million.

For earnings history and earnings-related data on Treace Medical Concepts, Inc. (TMCI) click here.

You May Also Be Interested In

• Amgen (AMGN) Tops Q2 EPS by 69c, Beats on Revenue; Offers FY26 Guidance
• Bnccorp, Inc. (BNCC) Tops Q2 EPS by 54c
• G. Willi-Food to delist from Nasdaq, shift to Tel Aviv exchange